| |
| |
| Oral |
| PERIPHERAL VASCULAR DISEASE |
| Adult:
10 mg tid. Maintenance: 5-10 mg tid. Max: Up to 60 mg daily in divided doses. |
| |
| Oral |
| TREATMENT OF SYMPTOMS OF MENTAL DETERIORATION ASSOCIATED WITH CEREBROVASCULAR INSUFFICIENCY |
| Adult:
10 mg tid. Maintenance: 5-10 mg tid. Max: Up to 60 mg daily in divided doses. |
| |
| Intravenous |
| PERIPHERAL VASCULAR DISEASE |
| Adult:
4-8 mg by slow IV infusion (over 30 min). |
| |
| Oral |
| TREATMENT OF SYMPTOMS OF MENTAL DETERIORATION ASSOCIATED WITH CEREBROVASCULAR INSUFFICIENCY |
| Adult:
4-8 mg by slow IV infusion (over 30 min). |
| |
| Intramuscular |
| PERIPHERAL VASCULAR DISEASE |
| Adult:
2-4 mg bid. |
| |
| Oral |
| TREATMENT OF SYMPTOMS OF MENTAL DETERIORATION ASSOCIATED WITH CEREBROVASCULAR INSUFFICIENCY |
| Adult:
2-4 mg bid. |
